Why is Mono Pharmacare falling/rising?

As of 19-Nov, Mono Pharmacare Ltd is experiencing a decline in its stock price, currently at Rs 19.70, which reflects a decrease of Rs 0.75 or 3.67%. The stock has underperformed significantly, with a 1-week return of -4.14% and a 1-month return of -6.19%. It is also trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, being only 2.81% away from it. Despite a rise in investor participation, with delivery volume increasing by 19.05% against the 5-day average, the overall performance remains weak, as indicated by the stock's substantial year-to-date decline of 43.15%.
In the broader market context, the Sensex has shown resilience with a 1-week gain of +0.68% and a year-to-date increase of +10.18%, contrasting sharply with Mono Pharmacare's poor performance. This divergence highlights the stock's struggles relative to the market, as it has not only underperformed the sector today by -4.47% but also lagged behind the benchmark over various time frames. The lack of available positive or negative factors further complicates the outlook, leaving the stock's recent movement primarily influenced by its own poor performance metrics rather than broader market trends.